Amgen 
Welcome,         Profile    Billing    Logout  
 160 Products   813 Diseases   160 Products   1618 Trials   78436 News 


«12...897898899900901902903904905906907...910911»
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Enrollment change:  Can We Miss Pigmented Lesions in Psoriasis Patients? (clinicaltrials.gov) -  Aug 20, 2012   
    P4,  N=6, Completed, 
    Recruiting --> Completed N=10 --> 6
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Trial completion:  Can We Miss Pigmented Lesions in Psoriasis Patients? (clinicaltrials.gov) -  Aug 20, 2012   
    P4,  N=6, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Trial completion, Surgery:  Preoperative Etanercept Before Inguinal Hernia Surgery (clinicaltrials.gov) -  Aug 19, 2012   
    P=N/A,  N=77, Completed, 
    Active, not recruiting --> Completed Enrolling by invitation --> Completed
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen, Humira (adalimumab) / AbbVie
    Enrollment change:  Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA) (clinicaltrials.gov) -  Aug 16, 2012   
    P4,  N=13, Terminated, 
    Enrolling by invitation --> Completed N=144 --> 13
  • ||||||||||  motesanib (AMG 706) / Takeda
    Trial termination, Combination therapy, Metastases:  MONET1-MOtesanib NSCLC Efficacy and Tolerability Study (clinicaltrials.gov) -  Aug 12, 2012   
    P3,  N=1450, Terminated, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Terminated; Amgen discontinued the development of AMG706 because 20050201 did not meet its primary objective.
  • ||||||||||  Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J, Enbrel (etanercept) / Pfizer, Amgen, Humira (adalimumab) / Eisai, AbbVie
    Clinical:  TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis (clinicaltrials.gov) -  Aug 2, 2012   
    P=N/A,  N=60, Recruiting,